Medicine
Enoxaparin 150 mg/1 mL injection
Enoxaparin 150 mg/1 mL injection is a generic prescription medicine for subcutaneous use, made by 13 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store at 25°C (77°F), excursions permitted to 15°C to 30°C (59°F to 86°F)…
Key facts
- Active ingredient (INN)
- Enoxaparin
- Brand
- Sold under the generic name
- Strength
- 150 mg/1 mL
- Dosage form
- Injection
- Route
- Subcutaneous
- Packs
- 10 syringes of 1 mL, 10 cello pack of 1 mL, 10 blister pack of 1 mL and 15 more
- Manufacturers
- Gland PharmaIndiaFresenius KabiSandozMeitheal PharmaceuticalsAmphastar PharmaceuticalsBE PharmaceuticalsBluePoint LaboratoriesHebei Changshan Biochemical PharmaceuticalHepalinkNorthStar Rx
- Origin register
- US FDA, United States
- Storage
- Store at 25°C (77°F), excursions permitted to 15°C to 30°C (59°F to 86°F). Store in the original carton or packaging until ready to use.
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- B01AB05 Enoxaparin
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 23 July 2010
- Identifiers
- RxCUI 854228, 854235, 854238 +5DailyMed set ID b7197534-1daa-42de-8b83-a727da1195bf, 20635579-c92d-4f6c-a332-1096d51002f2, 419a3566-4f67-4c8d-86e5-c00c7ec429e1 +14NDC 71839-116, 0955-1015, 25021-411 +13Application ANDA214646, NDA020164, ANDA078990 +5
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
Packs from every labeler of this generic presentation.
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 10 syringe in 1 carton / 1 mL in 1 syringe | 68083-640-10 | Gland PharmaIndia | 11 July 2023 |
| 10 cello pack in 1 carton / 1 syringe in 1 cello pack / 1 mL in 1 syringe | 63323-537-84 | Fresenius Kabi | 18 June 2019 |
| 10 cello pack in 1 carton / 1 syringe in 1 cello pack / 1 mL in 1 syringe | 63323-537-94 | Fresenius Kabi | 18 June 2019 |
| 10 blister pack in 1 carton / 1 syringe in 1 blister pack / 1 mL in 1 syringe | 63323-589-94 | Fresenius Kabi | 23 April 2019 |
| 10 syringe in 1 carton / 1 mL in 1 syringe | 0781-3299-69 | Sandoz | 16 February 2021 |
| 10 syringe in 1 carton / 1 mL in 1 syringe | 0781-3510-63 | Sandoz | 28 September 2026 |
| 10 syringe in 1 carton / 1 mL in 1 syringe | 0781-3513-63 | Sandoz | 28 September 2026 |
| 10 syringe in 1 carton / 1 mL in 1 syringe | 71288-438-94 | Meitheal Pharmaceuticals | 1 December 2019 |
| 10 syringe in 1 carton / 1 mL in 1 syringe | 71288-438-96 | Meitheal Pharmaceuticals | 1 December 2019 |
| 10 syringe in 1 carton / 1 mL in 1 syringe | 0548-5607-00 | Amphastar Pharmaceuticals | 19 September 2011 |
| 10 syringe in 1 carton / 1 mL in 1 syringe | 71839-116-10 | BE Pharmaceuticals | 16 June 2023 |
| 10 syringe in 1 carton / 1 mL in 1 syringe | 28955-107-10 | Hebei Changshan Biochemical Pharmaceutical | 1 May 2026 |
| 10 syringe in 1 carton / 1 mL in 1 syringe | 81952-135-06 | Hepalink | 27 April 2023 |
| 10 syringe in 1 carton / 1 mL in 1 syringe | 25021-411-71 | Sagent Pharmaceuticals | 1 October 2023 |
| 10 cello pack in 1 carton / 1 syringe in 1 cello pack / 1 mL in 1 syringe | 0955-1015-10 | Sanofi-Aventis | 3 October 2011 |
| 10 syringe in 1 carton / 1 mL in 1 syringe | 68001-639-42 | BluePoint Laboratories | 15 April 2025 |
| 10 syringe in 1 carton / 1 mL in 1 syringe | 16714-066-10 | NorthStar Rx | 1 December 2019 |
| 10 syringe in 1 carton / 1 mL in 1 syringe | 72603-225-10 | NorthStar RxLLC | 14 July 2023 |
| 10 syringe in 1 carton / 1 mL in 1 syringe | 70710-1763-6 | — | 1 April 2021 |
| 10 syringe in 1 carton / 1 mL in 1 syringe | 11797-763-06 | — | 1 April 2021 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Alternatives
Other makers and brands of Enoxaparin 150 mg/1 mL injection.
Other strengths and forms of Enoxaparin
Clinical summary
Enoxaparin is a low molecular weight heparin indicated for prophylaxis of deep vein thrombosis (DVT) in abdominal surgery, hip replacement surgery, knee replacement surgery, or medical patients with severely restricted mobility during acute illness. MedsAcross supplies Enoxaparin for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about EnoxaparinFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- Enoxaparin sodium prescribing information (Sanofi-Aventis) · U.S. National Library of Medicine, DailyMed
- Inhixa: European public assessment report (EPAR) · European Medicines Agency
Need Enoxaparin 150 mg/1 mL injection for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.